DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

R. L. Hansen, T. S. Jørgensen, A. Egeberg, N. Lippert Rosenoe, M. Skougaard, Z. R. Stisen, L. Dreyer, L. E. Kristensen

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerPOS1018
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind81
Udgave nummerSuppl. 1
Sider (fra-til)819-820
Antal sider2
ISSN0003-4967
DOI
StatusUdgivet - jun. 2022
BegivenhedAnnual European Congress of Rheumatology, EULAR 2022 - Copenhagen, Danmark
Varighed: 1 jun. 20224 jun. 2022
https://www.congress.eular.org/

Konference

KonferenceAnnual European Congress of Rheumatology, EULAR 2022
Land/OmrådeDanmark
ByCopenhagen
Periode01/06/202204/06/2022
Internetadresse

Bibliografisk note

Abstrakt No. POS1018

Citationsformater